Institutional investors purchased a net $11.0 million shares of CYTR during the quarter ended June 2016. This may signal that the smart money is gaining interest in this company as the 36.60% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Other industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SABBY CAPITAL LLC Bought 9.3 Million shares of CytRx Corp
HEIGHTS CAPITAL MANAGEMENT, INC. Bought 3.9 Million shares of CytRx Corp
THE VANGUARD GROUP, INC. Bought 141.5 Thousand shares of CytRx Corp